Mehrad Mahmoudian
mehmah@utu.fi Tykistökatu 6 Turku ORCID identifier: https://orcid.org/0000-0001-7650-1862 |
Areas of expertise
Statistical Data Analysis, Survival Analysis, Machine Learning
Statistical Data Analysis, Survival Analysis, Machine Learning
Publications
- Cell type markers indicate distinct contributions of decidual stromal cells and natural killer cells in preeclampsia (2022)
- Reproduction
(A1 Refereed original research article in a scientific journal) - Histone H3K4me3 breadth in hypoxia reveals endometrial core functions and stress adaptation linked to endometriosis (2022)
- iScience
(A1 Refereed original research article in a scientific journal) - Differential ATAC-seq and ChIP-seq peak detection using ROTS (2021)
- NAR Genomics and Bioinformatics: Nucleic Acids Research Genomics and Bioinformatics
(A1 Refereed original research article in a scientific journal) - Stable Iterative Variable Selection (2021)
- Bioinformatics
(A1 Refereed original research article in a scientific journal) - Data-Independent Acquisition Mass Spectrometry in Metaproteomics of Gut Microbiota—Implementation and Computational Analysis (2020)
- Journal of Proteome Research
(A1 Refereed original research article in a scientific journal) - (2020)
- Journal of Hypertension
- Transcriptomic responses to hypoxia in endometrial and decidual stromal cells2020
- Reproduction
(A1 Refereed original research article in a scientific journal) - A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer (2019)
- F1000Research
(A1 Refereed original research article in a scientific journal) - 2019
- Scandinavian Journal of Urology
- A crowdsourced analysis to identify ab initio molecular signatures predictive of susceptibility to viral infectionReply to Tuomas Mirtti and Tero Aittokallio's Letter to the Editor re: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838-40. Clinical Utility of Trial-estimated Prognostic Models.2018
- Nature CommunicationsEuropean Urology
(A1 Refereed original research article in a scientific journal) - A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer (2017)
- F1000Research
(A1 Refereed original research article in a scientific journal) - (2017)
- European Urology
(B1 Non-refereed article in a scientific journal) - (2017)
- Lancet Oncology
(A1 Refereed original research article in a scientific journal) - (2017)
(B1 Non-refereed article in a scientific journal)